Medication
Sandoz Olanzapine ODT
DIN 02327775 · Sandoz Canada Incorporated Likely a generic
What it is
- Active ingredients
- Olanzapine — 5 mg
- Form and route
- Tablet (Orally-Disintegrating) · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2010-02-26
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Zyprexa
- Zyprexa Zydis
- Teva-Olanzapine
- Apo-Olanzapine
- PMS-Olanzapine
- PMS-Olanzapine ODT
- Sandoz Olanzapine
- Olanzapine
- Olanzapine ODT
- Olanzapine ODT
- Olanzapine ODT
- Apo-Olanzapine ODT
- Olanzapine
- Olanzapine
- Jamp Olanzapine ODT
- Mint-Olanzapine
- Jamp Olanzapine FC
- Mint-Olanzapine ODT
- Auro-Olanzapine ODT
- Nra-Olanzapine ODT
- Nra-Olanzapine
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Nervous system
- ATC code
- N05AH03
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of N05AH03, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.